t(14;19)(q11;q13) TRA/NECTIN2 by Huret, Jean Loup
Leukaemia Section 
Short Communication 
Atlas Genet Cytogenet Oncol Haematol. 2020; 24(6) 253 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
t(14;19)(q11;q13) TRA/NECTIN2 
Jean Loup Huret 
jean-loup.huret@atlasgeneticsoncology.org 
Published in Atlas Database: September 2019 
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1419q11q13TRANECTIN2ID1513.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/70751/09-2019-t1419q11q13TRANECTIN2ID1513.pdf 
DOI: 10.4267/2042/70751
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2020 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Review on t(14;19)(q11;q13), with data on clinics, 
and the genes involved. 
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Four cases available to date: three peripheral T-cell 
lymphoma not otherwise specified (PTCL-NOS) 
(two male patients aged 20 and 63 yrs and one 
female patient aged 63 yrs), and one 
angioimmunoblastic T-cell lymphoma (Lepretre et 
al., 2000; Almire et al., 2007; Shin et al., 212). 
Cytogenetics 
Cytogenetics morphological 
The karyotype was complex in all four cases. 
Genes involved and 
proteins 
TRA (T cell Receptor Alpha) 
Location 14q11.2 




NECTIN2 is also called PVRL2 (poliovirus 
receptor-related 2). 
Protein 
NECTIN2 is a cell membrane protein involved in 
immune checkpoint, part of the TIGIT-PVR/PVRL2 
axis. NECTIN2 is composed of a signal peptide 
(amino acids (aa) 1-31), an extracellular domain (aa 
32-360), a transmembrane domain (aa 361-381), and 
a cytoplasmic domain (aa 382-538). NECTIN2 also 
interacts with PVRIG CD226, CD96 to stimulate or 
inhibit lymphocyte cell signaling (Stamm et al., 
2018; Whelan et al., 2019). 
Result of the chromosomal 
anomaly 
Hybrid gene 
On chromosome 19, there was a cluster of 
breakpoints in the NECTIN2 gene region, 130 kb 
downstream of BCL3. The breakpoints on 
chromosome 14 were located in theTRAJ region 
(Almire et al., 2007). 
Fusion protein 
Oncogenesis 
NECTIN2 was highly expressed in the 
t(14;19)(q11;q13)-positive tumors. 
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